Drug Type Chemical drugs |
Synonyms- |
Target |
Action modulators |
Mechanism STK11 modulators(serine/threonine kinase 11 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peutz-Jeghers Syndrome | Preclinical | United States | 04 Aug 2024 |